According to reliable sources, Willis Towers Watson PLC WLTW has stalled its plans to sell its wholesale brokerage business, Miller Insurance Services LP. This suspension happened due to the subdued business environment and economic uncertainty amid the breakout of the COVID-19 pandemic, which sparked recessionary fears across the globe.
This sale was supposed to be made by the company to Aon Plc. AON, which inked a deal earlier last month to acquire the former for nearly $30 billion. Per the terms of the agreement, Aon’s acquisition of Willis Towers Watson will be the biggest ever in the insurance industry in an all-stock transaction, thereby creating the world’s largest insurance broker worth of $80 billion.
The buyout of Willis Towers Watson by Aon will be a win-win situation for both parties. Therefore, the company is streamlining its operations to make its business portfolio more attractive.
WillisTowers Watson acquired Miller Insurance just more than three years ago. The business is performing quite well and its revenues increased 15% on an organic basis in the fourth quarter of 2019, driven by growth across its book.
Willis Towers Watson’s operating performance has been favorable. Commissions and fees, which forms a major component of the company’s revenue base continues to grow from the past many quarters. Commissions and fees associated with business transactions showed a marked improvement, backed by organic growth across segments and a rich contribution from integrations.
Further, the company’s geographic diversification supports its overall growth. With solid customer-retention levels and an expanding new business, we expect the company to bump up its revenues. For 2020, the company expects organic revenue growth of around 4-5% and 6-7% on an overall constant currency basis.
The stock has declined 22% year to date compared with its industry’s decrease of 25%.
Two other companies in the same space with stock price depreciation are Arthur J. Gallagher & CO. AJG and Brown and Brown, Inc. BRO, which have lost 19.9% and 15.4%, respectively, so far this year.
Willis Towers Watson carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>